Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan 22;1(1):CD010542.
doi: 10.1002/14651858.CD010542.pub2.

Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease

Chavdar S Pavlov  1 , Giovanni Casazza, Dimitrinka Nikolova, Emmanuel Tsochatzis, Andrew K Burroughs, Vladimir T Ivashkin, Christian Gluud
Affiliations
Review

Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease

Chavdar S Pavlov et al. Cochrane Database Syst Rev. .

Abstract

Background: The presence and progression of hepatic (liver) fibrosis into cirrhosis is a prognostic variable having impact on survival in people with alcoholic liver disease. Liver biopsy, although an invasive method, is the recommended 'reference standard' for diagnosis and staging of hepatic fibrosis in people with liver diseases. Transient elastography is a non-invasive method for assessing and staging hepatic fibrosis.

Objectives: To determine the diagnostic accuracy of transient elastography for diagnosis and staging hepatic fibrosis in people with alcoholic liver disease when compared with liver biopsy. To identify the optimal cut-off values for differentiating the five stages of hepatic fibrosis.

Search methods: The Cochrane Hepato-Biliary Group Controlled and Diagnostic Test Accuracy Studies Registers, The Cochrane Library, MEDLINE (OvidSP), EMBASE (OvidSP), and the Science Citation Index Expanded (last search August 2014).

Selection criteria: Diagnostic cohort and diagnostic case-control study designs that assessed hepatic fibrosis in participants with alcoholic liver disease with transient elastography and liver biopsy, irrespective of language or publication status. The study participants could be of any sex and ethnic origin, above 16 years old, hospitalised or managed as outpatients. We excluded participants with viral hepatitis, autoimmunity, metabolic diseases, and toxins.

Data collection and analysis: We followed the guidelines in the draft Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy.

Main results: Five retrospective and nine prospective cohort studies with 834 participants provided data for the review analyses. Authors of seven of those studies sent us individual participant data. The risk of bias in the included studies was high in all but three studies. We could identify no serious concerns regarding the applicability of the studies in answering the main study question of our review, namely to use transient elastography to diagnose hepatic fibrosis. We could not identify the optimal cut-off values for the fibrosis stages. The definition of the diagnosis of alcoholic liver disease was not provided in one study and was not clearly defined in two studies, but it was clear in the remaining 11 studies. The study authors used different liver stiffness cut-off values of transient elastography for the hepatic fibrosis stages.There was only one study (103 participants) with data on hepatic fibrosis stage F1 or worse, with a cut-off of 5.9 kPa, and reporting sensitivity of 0.83 (95% confidence interval (CI) 0.74 to 0.90) and specificity of 0.88 (95% CI 0.47 to 1.00). The summary sensitivity and specificity of transient elastography for F2 or worse (seven studies with 338 participants and with cut-offs around 7.5 kPa (range 7.00 to 7.8 kPa)) were 0.94 and 0.89 with LR+ 8.2 and LR- 0.07, which suggests that transient elastography could be useful to rule out the presence of significant hepatic fibrosis, thus avoiding liver biopsy.Due to the wide range of cut-off values (from 8.0 to 17.0 kPa) found in the 10 studies with 760 participants with hepatic fibrosis F3 or worse, we fitted a hierarchical summary receiver operating characteristic (HSROC) model and estimated a summary ROC (SROC) curve. The sensitivity of the 10 studies varied from 72% to 100% and the specificity from 59% to 89%. We performed an additional analysis by including the studies with a cut-off value of around and equal to 9.5 kPa (range 8.0 to 11.0 kPa). The summary sensitivity and specificity of transient elastography (eight studies with 564 participants) were 0.92 and 0.70 with LR+ 3.1 and LR- 0.11, which suggests that transient elastography could also be useful to rule out the presence of severe hepatic fibrosis (F3 or worse), avoiding liver biopsy. We carried out a sensitivity analysis by considering only the studies with a cut-off value equal to 9.5 kPa and the result did not differ.We performed an HSROC analysis and reported an SROC curve for hepatic fibrosis stage F4 (cirrhosis). The HSROC analysis suggested that when the cut-off value changes, there is a wide variation in specificity and a more limited variation in sensitivity. We performed an additional analysis with the studies with the most commonly used cut-off value of 12.5 kPa. The summary sensitivity and specificity of transient elastography (seven studies with 330 participants) were 0.95 and 0.71 with LR+ 3.3 and LR- 0.07, which again suggests that transient elastography could be useful to rule out the presence of cirrhosis, avoiding liver biopsy.

Authors' conclusions: We identified a small number of studies with a few participants and were unable to include several studies, which raises the risk of outcome reporting bias. With these caveats in mind, transient elastography may be used as a diagnostic method to rule out liver cirrhosis (F4) in people with alcoholic liver disease when the pre-test probability is about 51% (range 15% to 79%). Transient elastography may also help in ruling out severe fibrosis (F3 or worse). Liver biopsy investigation remains an option if the certainty to rule in or rule out the stage of hepatic fibrosis or cirrhosis remains insufficient after a clinical follow-up or any other non-invasive test considered useful by the clinician.The proposed cut-off values for the different stages of hepatic fibrosis may be used in clinical practice, but caution is needed, as those values reported in this review are only the most common cut-off values used by the study authors. The best cut-off values for hepatic fibrosis in people with alcoholic liver disease could not be established yet.In order to diagnose correctly the stage of hepatic fibrosis in people with alcoholic liver disease using transient elastography assessment, the studies should consider a single aetiology. Hepatic fibrosis should be diagnosed with both transient elastography and liver biopsy and in this sequence, and transient elastography cut-off values should be pre-specified and validated. The time interval between the two investigations should not exceed three months, which is the interval mainly valid for people without cirrhosis, and assessment of results should be properly blinded. Only studies with low risk of bias, fulfilling the Standards for Reporting of Diagnostic Accuracy may answer the review question.

PubMed Disclaimer

Conflict of interest statement

Chavdar Pavlov: none known. Giovanni Casazza: none known. Dimitrinka Nikolova: none known. Emmanuel Tsochatzis: none known. Andrew K Burroughs: none known. Vladimir T Ivashkin: none known. Christian Gluud: none known.

Figures

1
1
Clinical pathway in the diagnosis of alcoholic liver disease.
2
2
Funnel plot for reporting bias for liver fibrosis F4 in 14 included studies Even though the Figure is not in the form of a funnel plot, it seems that there is no clear indication of reporting bias as the points were equally distributed along the x‐ and y‐axes. There seems to be two outliers (to the right) (Bardou‐Jacquet 2013; Carl 2012): both studies had a small number of participants (eight and four).
3
3
Flow chart.
4
4
Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies.
5
5
Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study.
6
6
Forest plot: Transient elastography for F2 or worse.
7
7
Summary operating point and 95% confidence region: Transient elastography for F2 or worse with cut‐offs around 7.5 kPa.
8
8
Forest plot: Transient elastography for F3 or worse.
9
9
Hierarchical summary receiver operating characteristic (ROC) curve: Transient elastography for F3 or worse. The cut‐offs in the nine studies ranged from 8.0 to 17.0 kPa.
10
10
Forest plot: Transient elastography for F3 or worse with cut‐offs around 9.5 kPa.
11
11
Summary operating point and 95% confidence region: Transient elastography for F3 or worse with cut‐offs around 9.5 kPa.
12
12
Forest plot: Transient elastography for F4.
13
13
Hierarchical summary receiver operating characteristic (ROC) curve: Transient elastography for F4.
14
14
Hierarchical summary receiver operating characteristic (ROC) curve: Transient elastography for F4 (cirrhosis): only studies with time interval between transient elastography and liver biopsy within three months.
15
15
Forest plot: Transient elastography for F4 (most common cut‐off = 12.5 kPa).
16
16
Summary operating point and 95% confidence region: Transient elastography for F4 (cirrhosis) with the most common cut‐off = 12.5 kPa.
1
1. Test
Transient elastography for F1 or worse.
2
2. Test
Transient elastography for F2 or worse.
3
3. Test
Transient elastography for F3 or worse.
4
4. Test
Transient elastography for F3 or worse with cut‐off values around 9.5.
5
5. Test
Transient elastography for F3 or worse with a cut‐off value equal to 9.5.
6
6. Test
Transient elastography for F4.
7
7. Test
Transient elastography for F4 (most common cut‐off value = 12.5).
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD010542

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Anastasiou 2010 {published data only}
    1. Anastasiou J, Alisa A, Virtue S, Portmann B, Murray‐Lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. European Journal of Gastroenterology & Hepatology 2010;22(4):474‐80. - PubMed
Bardou‐Jacquet 2013 {published data only}
    1. Bardou‐Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc'h A, Lan C, et al. Effect of alcohol consumption on liver stiffness measured by transient elastography. World Journal of Gastroenterology 2013;19(4):516‐22. - PMC - PubMed
Boursier 2009 {published data only}
    1. Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, et al. The combination of a blood test and FibroScan improves the non‐invasive diagnosis of liver fibrosis. Liver International 2009;29(10):1507‐15. - PubMed
Carl 2012 {published and unpublished data}
    1. Carl I, Addley J, McDoughall NI, Cash WJ. Transient hepatic elastography reliably excludes cirrhosis in an unselected liver disease population. Journal of Hepatology 2012;56:S389‐548.
de Ledinghen 2013 {published data only}
    1. Foucher J, Chanteloup E, Vergniol J, Castéra L, Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55(3):403‐8. - PMC - PubMed
    1. Ganne‐Carrié N, Ziol M, Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44(6):1511‐7. - PubMed
    1. Ledinghen V. (See notes in Included studies table). (Personal communication) 2013.
    1. Ledinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan. Journal of Hepatology 2012;56(4):833‐9. - PubMed
Dolman 2013 {published data only}
    1. Dolman GE, Nieboer D, Steyerberg EW, Harris S, Ferguson A, Zaitoun AM, et al. The performance of transient elastography compared to clinical acumen and routine tests ‐ what is the incremental diagnostic value?. Liver International 2013; Vol. 33, issue 2:172‐9. - PubMed
Fernandez 2012 {published data only}
    1. Fernandez M. FibroScan (transient elastography) is the most reliable non‐invasive method for the assessment of severe fibrosis and cirrhosis in alcoholic liver disease [poster for AASLD 2012]. www.biopredictive.com. (accessed 1 December 2014).
Janssens 2010 {published data only}
    1. Janssens F, Suray N, Piessevaux H, Horsmans Y, Timary P, Stärkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real‐life study. Journal of Clinical Gastroenterology 2010;44(8):575‐82. - PubMed
Kim 2009 {published data only}
    1. Kim SG, Kim YS, Jung SW, Kim HK, Jang JY, Moon JH, et al. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Korean Journal of Hepatology 2009;15(1):42‐51. - PubMed
Lannerstedt 2013 {published data only}
    1. Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW. Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver. Scandinavian Journal of Gastroenterology 2013;48(1):93‐100. - PubMed
Lemoine 2008 {published data only}
    1. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne‐Carrie N, Kazemi F, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis. Alimentary Pharmacology & Therapeutics 2008;28(9):1102‐10. - PubMed
Mueller 2010 {published data only}
    1. Mueller S, Millonig G, Friedrich S, Stickel F, Longerich T, Schirmacher P, et al. Increased liver stiffness in alcoholic liver disease: dissecting fibrosis from steatohepatitis. Alcoholism, Clinical and Experimental Research 2010;34(Suppl S3):141A. - PMC - PubMed
    1. Mueller S, Millonig G, Friedrich S, Stickel F, Longerich T, Schirmacher P, et al. Increased liver stiffness in alcoholic liver disease: dissecting fibrosis from steatohepatitis. Journal of Hepatology 2010;52(Suppl 1):S169. - PMC - PubMed
    1. Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World Journal of Gastroenterology 2010;16(8):966‐72. - PMC - PubMed
    1. Mueller S, Millonig G, Sarovska L, Friedrich SS, Reimann FM, Pritsch M, et al. Alcoholic steatohepatitis increases liver stiffness independent of fibrosis stage: criteria for noninvasive fibrosis assessment. Gastroenterology 2009;136(5 Suppl 1):A‐420.
    1. Mueller S, Millonig G, Stickel F, Longerich T, Schirmacher P, Seitz HK, et al. Improved diagnostic accuracy of transient elastography for cirrhosis using histology plus clinics as gold standard. Journal of Hepatology 2010;52(Suppl 1):S168.
Nahon 2008 {published data only}
    1. Nahon P, Kettaneh A, Tengher‐Barna I, Ziol M, Lédinghen V, Douvin C, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. Journal of Hepatology 2008;49(6):1062‐8. - PubMed
Nguyen‐Khac 2008 {published data only}
    1. Balabaud CP, Bioulac‐Sage P. Transient elastography: is liver stiffness in alcoholic patients all fibrosis? (comment). Alimentary Pharmacology & Therapeutics 2009;29(12):1309‐10. - PubMed
    1. Nguyen‐Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using FibroScan: prospective comparison with seven non‐invasive laboratory tests. Alimentary Pharmacology & Therapeutics 2008;28(10):1188‐98. - PubMed

References to studies excluded from this review

Angulo 2009b {published data only}
    1. Angulo P. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Gastroenterologie Clinique et Biologique 2009; Vol. 33, issue 10‐11:940‐8. - PubMed
Baba 2011 {published data only}
    1. Baba M, Furuya K, Bandou H, Kasai K, Sadaoka K. Discrimination of individuals in a general population at high‐risk for alcoholic and non‐alcoholic fatty liver disease based on liver stiffness: a cross section study. BMC Gastroenterology 2011;11:70. - PMC - PubMed
Bureau 2008 {published data only}
    1. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics 2008;27(12):1261‐8. - PubMed
Crespo 2010 {published data only}
    1. Crespo G, Fernandez‐Varo G, Martinez SM, Miquel R, Gilabert R, Forns X, et al. Non invasive assessment of liver fibrosis using acoustic radiation force impulse (ARFI): a prospective comparison with transient elastography and serum markers. Hepatology 2010;52(Suppl S1):962A.
Crespo 2012 {published data only}
    1. Crespo G, Fernandez‐Varo G, Marino Z, Casals G, Miquel R, Martinez SM, et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. Journal of Hepatology 2012;57(2):281‐7. - PubMed
Ebinuma 2011 {published data only}
    1. Ebinuma H, Saito H, Komuta M, Ojiro K, Wakabayashi K, Usui S, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FibroScan®. Journal of Gastroenterology 2011;46:1238‐48. - PubMed
Fraquelli 2007 {published data only}
    1. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56(7):968‐73. - PMC - PubMed
Ganne‐Carrié 2006 {published data only}
    1. Ganne‐Carrié N, Ziol M, Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44(6):1511‐7. - PubMed
Gómez‐Dominguez 2006 {published data only}
    1. Gómez‐Dominguez E, Mendoza J, Rubio S, Moreno‐Monteagudo JA, Garcia‐Buey L, Moreno‐Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics 2006;24(3):513‐8. - PubMed
Ingiliz 2009 {published data only}
    1. Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, et al. Applicability and variability of liver stiffness measurements according to probe position. World Journal of Gastroenterology 2009;15(27):3398‐404. - PMC - PubMed
Kircheis 2012 {published data only}
    1. Kircheis G, Sagir A, Vogt C, Vom Dahl S, Kubitz R, Häussinger D. Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World Journal of Gastroenterology 2012;18(10):1077‐84. - PMC - PubMed
Klibansky 2012 {published data only}
    1. Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal NH. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. Journal of Viral Hepatitis 2012;19(2):e184‐93. - PubMed
Krawczyk 2011 {published data only}
    1. Krawczyk M, Grünhage F, Zimmer V, Lammert L. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non‐invasive elastography‐based study in chronic liver disease. Journal of Hepatology 2011;55(2):299‐306. - PubMed
Marinho 2007 {published data only}
    1. Marinho R, Serejo F, Velosa J, Moura MC. Clinical usefulness of transitory hepatic elastography (FibroScan®) in the diagnosis of cirrhosis [Utilidade da elastografia hepática transitória (FibroScan®) na cirrose hepática]. Jornal Português de Gastrenterologia 2007;14(1):16‐21. [ 0872‐8178]
McCorry 2012 {published data only}
    1. McCorry RB, Palaniyappan N, Chivinge A, Kaye P, James MW, Aithal GP. Development and evaluation of a nurse‐led transient elastography service for the staging of hepatic fibrosis in patients with suspected chronic liver disease. QJM: Monthly Journal of the Association of Physicians 2012;105(8):749‐54. - PubMed
Nudo 2008 {published data only}
    1. Nudo CG, Jeffers LJ, Bejarano PA, Servin‐Abad LA, Leibovici Z, Medina M, et al. Correlation of laparoscopic liver biopsy to elasticity measurements (FibroScan) in patients with chronic liver disease. Gastroenterology & Hepatology 2008;4(12):862‐70. - PMC - PubMed
Rath 2011 {published data only}
    1. Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, et al. YKL‐40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 2011;46:1369‐80. - PubMed
Roulot 2011 {published data only}
    1. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community‐based population aged over 45 years. Gut 2011;60(7):977‐84. - PubMed
Stål 2009 {published data only}
    1. Stål P, Seth E, Bergquist A, Nemeth A, Weiland O. Elastography ‐ a new tool for diagnosis of chronic liver diseases. Might replace liver biopsy, but not always. Läkartidningen 2009;106(50‐51):3412‐4. - PubMed
Trabut 2012 {published data only}
    1. Trabut J, Thepot V, Nalpas B, Pol S. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcoholism, Clinical and Experimental Research 2012; Vol. 36, issue 8:1407‐11. - PubMed

Additional references

Angulo 2009a
    1. Angulo P. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Gastroenterologie Clinique et Biologique 2009;33(10‐11):940‐8. - PubMed
Becker 1996
    1. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch‐Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23(5):1025‐9. - PubMed
Bercoff 2004
    1. Bercoff J, Tanter M, Fink M. Supersonic shear imaging: a new technique for soft tissue elasticity imaging. IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control 2004;51(4):396‐409. - PubMed
Bouchier 1992
    1. Bouchier IA, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. Journal of Hepatology 1992;16:290‐7. - PubMed
Bruha 2012
    1. Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World Journal of Hepatology 2012;4(3):8‐90. - PMC - PubMed
Brunt 1999
    1. Brunt EM, Janney CG, Bisceglie AM, Neuschwander‐Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology 1999;94(9):2467‐74. - PubMed
Caballeria 1998
    1. Caballeria J, Pares A, Bru C, Mercader J, Garcia Plaza A, Caballeria L, et al. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double‐blind, placebo‐control trial Spanish Group for the Study of Alcoholic Fatty Liver. Journal of Hepatology 1998;28(1):54‐60. - PubMed
Castera 2010
    1. Castera L, Pinzani M. Biopsy and non‐invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut 2010;59(7):861‐6. - PubMed
Colli 2010
    1. Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 2010; Vol. 257:872‐8. [DOI: 10.1002/hep.26948] - DOI - PubMed
Colli 2014
    1. Colli A, Fraquelli M, Casazza G, Conte D, Nikolova D, Duca P, et al. The architecture of diagnostic research: from bench to bedside ‐ research guidelines using liver stiffness as an example. Hepatology 2014;60(1):408‐18. - PubMed
de Lédinghen 2008
    1. Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastroentérologie Clinique et Biologique 2008;32(6 Suppl 1):58‐67. - PubMed
de Lédinghen 2010
    1. Lédinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Review of Medical Devices 2010;7(6):811‐23. - PubMed
de Vet 2008
    1. Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: Searching for Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008.
Deeks 2005
    1. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58(9):882‐93. [PUBMED: 16085191] - PubMed
Desmet 1994
    1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513‐20. - PubMed
Dufour 2000
    1. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic Injury. I. Performance characteristics of laboratory tests. Clinical Chemistry 2000;46:2027‐49. - PubMed
Ersoz 1999
    1. Ersoz G, Demir A, Akarca OS, Yilmaz F, Ozutemiz O, Karasu Z, et al. The value of ultrasonography in the diagnosis of early cirrhosis. Turkish Journal of Gastroenterology 1999;10(1):7‐10.
Foucher 2006
    1. Foucher J, Chanteloup E, Vergniol J, Castéra L, Bail B, Adhoute X. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403‐8. - PMC - PubMed
Franciscus 2007
    1. Franciscus A. HCV diagnostic tools: grading and staging a liver biopsy (version 2.2), 2007. www.hcvadvocate.org (accessed 7 February 2011).
Friedrich‐Rust 2008
    1. Friedrich‐Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta‐analysis. Gastroenterology 2008;134(4):960‐74. [PUBMED: 18395077] - PubMed
Gluud 2007
    1. Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. Journal of Hepatology 2007;46(4):734‐42. - PubMed
Goodman 2007
    1. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology 2007;47(4):598‐607. - PubMed
Grant 1999
    1. Grant A. Guidelines on the use of liver biopsy in clinical practice. Gut 1999;45(Suppl 4):IV1‐11. [DOI: 10.1136/gut.45.2008.iv1] - DOI - PMC - PubMed
Gómez‐Domínguez 2006
    1. Gómez‐Domínguez E, Mendoza J, Rubio S, Moreno‐Monteagudo JA, García‐Buey L, Moreno‐Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics 2006;24(3):513‐8. - PubMed
Haque 2010
    1. Haque M, Robinson C, Owen D, Yoshida EM, Harris A. Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: a pilot study. Annals of Hepatology 2010;9(3):289‐93. - PubMed
Hizli 2010
    1. Hizli S, Kocyigit A, Arslan N, Tuncel S, Demircioglu F, Cakmakci H, et al. The role of ultrasonographic hepatic artery resistive index in the diagnosis of insulin resistance in obese children with non‐alcoholic fatty liver disease. Turkish Journal of Medical Sciences 2010;40(3):335‐42.
Ishak 1995
    1. Ishak K, Baptista A, Bianchi L, Callea F, Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. Journal of Hepatology 1995;22:696‐9. - PubMed
Ismail 2011
    1. Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepatic Medicine: Evidence and Research 2011;3:69‐80. - PMC - PubMed
Ivashkin 2011a
    1. Ivashkin VT, Pavlov CS. Non‐invasive diagnostic of liver fibrosis. Liver elastometry. In: Ivashkin VT, Pavlov CS editor(s). Liver Fibrosis. Moscow: Geotar‐Media, 2011:76‐85. [ISBN 978‐5‐9704‐1893‐2]
Ivashkin 2011b
    1. Ivashkin VT, Pavlov CS. Liver biopsy and morphological investigation of chronic liver disease. In: Ivashkin VT, Pavlov CS editor(s). Liver Fibrosis. Moscow: Geotar‐Media, 2011:13‐22. [ISBN 978‐5‐9704‐1893‐2]
Iyo 2009
    1. Iyo AY. Acoustic radiation force impulse imaging: a literature review. Journal of Diagnostic Medical Sonography 2009;25(4):204‐11.
Jin 2007
    1. Jin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clinical Gastroenterology and Hepatology 2007;5(10):1207‐13.e2. - PMC - PubMed
Jüni 1999
    1. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta‐analysis. JAMA 1999;282(11):1054‐60. - PubMed
Kim 2012
    1. Kim BK, Kim SU, Choi GH, Han WK, Park MS, Kim EH, et al. "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. Journal of Gastroenterology and Hepatology 2012;27(4):781‐8. - PubMed
Kleiner 2005
    1. Kleiner DE, Brunt EM, Natta M, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313‐21. - PubMed
Knodell 1981
    1. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1(5):431‐5. - PubMed
Kuntz 2008
    1. Kuntz E, Kuntz H‐D. Hepatology. 3rd Edition. Berlin: Springer Medizin Verlag, 2008.
Lijmer 1999
    1. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Meulen JH, et al. Empirical evidence of design‐related bias in studies of diagnostic tests. JAMA 1999;282(11):1061‐6. - PubMed
Liu 2012
    1. Liu T, Wang X, Karsdal MH, Leeming DJ, Genovese F. Molecular serum markers of liver fibrosis. Biomark Insights 2012;7:105‐17. - PMC - PubMed
Macaskill 2010
    1. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0 [updated September 2010]. The Cochrane Collaboration, 2010. Available from: http://srdta.cochrane.org/.
Morra 2007
    1. Morra R, Munteanu M, Imbert‐Bismut F, Messous D, Ratziu V, Poynard T. FibroMAX: towards a new universal biomarker of liver disease?. Expert Review of Molecular Diagnostics 2007;7(5):481‐90. - PubMed
Myers 2010
    1. Myers RP, Elkashab M, Ma M, Crotty P, Pomier‐Layrargues G. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Canadian Journal of Gastroenterology 2010;24(11):661‐70. - PMC - PubMed
Nahon 2009
    1. Nahon P, Kettaneh A, Lemoine M, Seror O, Barget N, Trinchet JC. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case‐control study. European Journal of Gastroenterology and Hepatology 2009;21(2):214‐9. - PubMed
Naveau 1997
    1. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25(1):108‐11. - PubMed
O'Shea 2010
    1. O'Shea RS, Dasarathy S, McCullough AJ, the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010;51(1):307‐28. - PubMed
Pavlov 2014a
    1. Pavlov CS, Casazza G, Tsochatzis M, Nikolova D, Gluud C. Ultrasonography for diagnosis of cirrhosis in patients with alcoholic liver disease. Cochrane Database of Systematic Reviews [in editorial consideration]. - PMC - PubMed
Pavlov 2014b
    1. Pavlov CS, Casazza G, Tsochatzis M, Nikolova D, Gluud C. Transient elastography and FibroTest® for diagnosis of hepatic fibrosis in adult patients with chronic hepatitis C. Cochrane Database of Systematic Reviews [under preparation].
Poulsen 1979
    1. Poulsen HE, Christoffersen P. Atlas of Liver Biopsies. Copenhagen: Munksgaard, 1979.
Poynard 2007
    1. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert‐Bismut F, et al. Meta‐analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterology 2007;7:40. [DOI: 10.1186/1471-230X-7-40] - DOI - PMC - PubMed
Poynard 2008
    1. Poynard T, Morra R, Ingiliz P, Imbert‐Bismut F, Thabut D, Messous D. Assessment of liver fibrosis: noninvasive means. Saudi Journal of Gastroenterology 2008;14(4):163‐73. - PMC - PubMed
Regev 2002
    1. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. American Journal of Gastroenterology 2002;97(10):2614‐8. - PubMed
Reitsma 2005
    1. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005; Vol. 58, issue 10:982‐90. - PubMed
RevMan 2012 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rockey 2008
    1. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134(1):8‐14. - PubMed
Rockey 2009
    1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009;49(3):1017‐44. - PubMed
Roulot 2008
    1. Roulot D, Czernichow S, Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. Journal of Hepatology 2008;48(4):606‐13. - PubMed
Royle 2003
    1. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603. - PubMed
Rutjes 2006
    1. Rutjes AW, Reitsma JB, Nisio M, Smidt N, Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. Canadian Medical Association Journal 2006;174(4):469‐76. - PMC - PubMed
Rutter 2001
    1. Rutter CA, Gatsonis CA. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20:2865‐84. - PubMed
Sagir 2008
    1. Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008;47:592‐5. - PubMed
Sandrin 2003
    1. Sandrin L, Fourquet B, Hasquenoph J‐M, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology 2003;29:1705‐13. - PubMed
Savolainen 1993
    1. Savolainen VT, Liesto K, Männikkö A, Penttilä A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcoholism, Clinical and Experimental Research 1993;17:1112‐7. - PubMed
Schoenfeld 1999
    1. Schoenfeld P, Guyatt G, Hamilton F, Laine L, Cook D, Bjorkman D, et al. An evidence‐based approach to gastroenterology diagnosis. Gastroenterology 1999;116:1230‐7. - PubMed
Seeff 2010
    1. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT‐C trial. Clinical Gastroenterology and Hepatology 2010;8:877‐83. - PMC - PubMed
Sherlock 1997
    1. Sherlock S, Dooley J. Alcohol and the liver. Diseases of the Liver and Biliary System. 10th Edition. Oxford: Blackwell Science, 1997:385‐403.
Smidt 2005
    1. Smidt N, Rutjes AW, Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, et al. Quality of reporting of diagnostic accuracy studies. Radiology 2005;235:347‐53. - PubMed
Stebbing 2010
    1. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A meta‐analysis of transient elastography for the detection of hepatic fibrosis. Journal of Clinical Gastroenterology 2010;44(3):214‐9. - PubMed
Stevenson 2012
    1. Stevenson M, Lloyd‐Jones M, Morgan MY, Wong R. Non‐invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol‐related liver disease: a systematic review and economic evaluation. Health Technology Assessment 2012; Vol. 16, issue 4:1‐174. - PMC - PubMed
Stewart 2001
    1. Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends in Molecular Medicine 2001;7(9):408‐13. - PubMed
Teli 1995
    1. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis and fibrosis in pure alcoholic fatty liver. Lancet 1995;356:987‐90. - PubMed
Tsochatzis 2011
    1. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta‐analysis of diagnostic accuracy. Journal of Hepatology 2011;54(4):650‐9. - PubMed
Whiting 2004
    1. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine 2004;140(3):189‐202. - PubMed
Whiting 2005
    1. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology 2005;5:19. - PMC - PubMed
Whiting 2011
    1. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529‐36. - PubMed
WHO
    1. World Health Organization. BMI classification. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed 21 January 2015).
WHO 2010
    1. World Health Organization. Global strategy to reduce the harmful use of alcohol, 2010. www.who.int/substance_abuse/alcstratenglishfinal.pdf (accessed 15 January 2015).
Yashima 2011
    1. Yashima Y, Tsujino T, Masuzaki R, Nakai Y, Hirano K, Tateishi R, et al. Increased liver elasticity in patients with biliary obstruction. Jornal of Gastroenterology 2011;46(1):86‐91. - PubMed
Yoshioka 2013
    1. Yoshioka K. How to adjust the inflammation‐induced overestimation of liver fibrosis using transient elastography?. Hepatology Research 2013;43(2):182‐4. - PubMed
Ziol 2005
    1. Ziol M, Handra‐Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41(1):48‐54. - PubMed

MeSH terms